RemeGen Co., Ltd. — Share Issue/Capital Change 2021

Jun 2, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [169 x 52] intentionally omitted <==

RemeGen Co., Ltd. 榮昌生物製藥 ( 煙台 ) 股份有限公司*

(A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 9995)

ANNOUNCEMENT REGARDING H SHARE FULL CIRCULATION COMPLETION OF THE CONVERSION AND LISTING OF UNLISTED SHARES

INTRODUCTION

References are made to the announcements (the “ Announcements ”) of RemeGen Co., Ltd.* 榮昌 生物製藥(煙台)股份有限公司 (the “ Company ”) dated March 25, 2021, May 10, 2021 and May 17, 2021 in relation to the official approval by the CSRC and the listing approval by the Stock Exchange regarding the implementation of the H share full circulation program of the Company.

Unless otherwise indicated, capitalized terms used in this announcement shall have the same meanings as those defined in the Announcements.

COMPLETION OF THE CONVERSION AND LISTING OF THE UNLISTED SHARES

The board of directors of the Company (the “ Board ”) is pleased to announce that the conversion of 71,232,362 Unlisted Shares into H Shares was completed on June 2, 2021. The Converted H Shares were allotted on June 2, 2021 and the listing of the Converted H Shares on the Stock Exchange will commence at 9:00 a.m. on June 3, 2021.

The holders of the Converted H Shares who are PRC nationals can only conduct trading of the Converted H Shares subject to the completion of the onshore arrangement procedures as set out in the announcement of the Company dated May 17, 2021.

1

SHARE CAPITAL STRUCTURE

Upon completion of the conversion and listing of the Unlisted Shares, the share capital structure of the Company is set out below:

Class of sharesDomestic SharesUnlisted Foreign SharesH SharesTotal number of issued Shares	Immediately before completion ofthe conversion and listing ofthe Unlisted SharesNumber ofSharesPercentage(approximately)239,294,29148.85%132,193,53426.99%118,348,87724.16%489,836,702100.00%	Immediately upon completion ofthe conversion and listing ofthe Unlisted SharesNumber ofSharesPercentage(approximately)230,248,59647.01%70,006,86714.29%189,581,23938.70%489,836,702100.00%	Immediately upon completion ofthe conversion and listing ofthe Unlisted SharesNumber ofSharesPercentage(approximately)230,248,59647.01%70,006,86714.29%189,581,23938.70%489,836,702100.00%
			100.00%

By order of the Board RemeGen Co., Ltd. Mr. Wang Weidong Chairman and executive director

Yantai, The People’s Republic of China June 2, 2021

As at the date of this announcement, the Board of the Company comprises Mr. Wang Weidong, Dr. Fang Jianmin, Dr. He Ruyi and Mr. Lin Jian as the executive directors, Dr. Wang Liqiang and Dr. Su Xiaodi as the non-executive directors, and Ms. Yu Shanshan, Mr. Hao Xianjing and Dr. Ma Lan as the independent non-executive directors.

• For identification purposes only

2